These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593 [TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings. Hradsky O; Ohem J; Mitrova K; Durilova M; Kotalova R; Nevoral J; Kolho KL; Bronsky J Clin Lab; 2014; 60(12):1993-2000. PubMed ID: 25651733 [TBL] [Abstract][Full Text] [Related]
4. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Sidler MA; Leach ST; Day AS Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298 [TBL] [Abstract][Full Text] [Related]
5. Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children: A Meta-analysis of Individual Patient Data. Holtman GA; Lisman-van Leeuwen Y; Day AS; Fagerberg UL; Henderson P; Leach ST; Perminow G; Mack D; van Rheenen PF; van de Vijver E; Wilson DC; Reitsma JB; Berger MY JAMA Pediatr; 2017 Oct; 171(10):984-991. PubMed ID: 28806445 [TBL] [Abstract][Full Text] [Related]
6. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission. Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048 [TBL] [Abstract][Full Text] [Related]
7. Fecal Calprotectin as a Screening Marker for Inflammatory Bowel Disease. Sridhar M; Kesavelu D Indian Pediatr; 2019 Mar; 56(3):249-250. PubMed ID: 30955002 [TBL] [Abstract][Full Text] [Related]
8. Immunoanalytical characteristics of fecal calprotectin. Desbène C; Gaillard O; Kapel N Ann Biol Clin (Paris); 2016 Dec; 74(6):725-734. PubMed ID: 27848924 [TBL] [Abstract][Full Text] [Related]
9. Interest of fecal calprotectine dosage in inflammatory bowel diseases, state of the art and perspectives. Chaabouni T; Manceau H; Peoc'h K Ann Biol Clin (Paris); 2016 Aug; 74(4):385-94. PubMed ID: 27492691 [TBL] [Abstract][Full Text] [Related]
11. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983 [TBL] [Abstract][Full Text] [Related]
12. Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders. Jeffery J; Lewis SJ; Ayling RM Inflamm Bowel Dis; 2009 Nov; 15(11):1630-4. PubMed ID: 19462434 [TBL] [Abstract][Full Text] [Related]
13. Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease. Ashorn S; Honkanen T; Kolho KL; Ashorn M; Välineva T; Wei B; Braun J; Rantala I; Luukkaala T; Iltanen S Inflamm Bowel Dis; 2009 Feb; 15(2):199-205. PubMed ID: 18618670 [TBL] [Abstract][Full Text] [Related]
14. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. van Rheenen PF; Van de Vijver E; Fidler V BMJ; 2010 Jul; 341():c3369. PubMed ID: 20634346 [TBL] [Abstract][Full Text] [Related]
15. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms. Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083 [TBL] [Abstract][Full Text] [Related]
16. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Konikoff MR; Denson LA Inflamm Bowel Dis; 2006 Jun; 12(6):524-34. PubMed ID: 16775498 [TBL] [Abstract][Full Text] [Related]
17. The role of fecal calprotectin in investigating inflammatory bowel diseases. Erbayrak M; Turkay C; Eraslan E; Cetinkaya H; Kasapoglu B; Bektas M Clinics (Sao Paulo); 2009 May; 64(5):421-5. PubMed ID: 19488608 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay. Diamanti A; Panetta F; Basso MS; Forgione A; Colistro F; Bracci F; Papadatou B; Francalanci P; Torroni F; Knafelz D; Fina F; Castro M Inflamm Bowel Dis; 2010 Nov; 16(11):1926-30. PubMed ID: 20310017 [TBL] [Abstract][Full Text] [Related]
19. The utility of fecal calprotectin in predicting the need for escalation of therapy in inflammatory bowel disease. Kwapisz L; Gregor J; Chande N; Yan B; Ponich T; Mosli M Scand J Gastroenterol; 2017 Aug; 52(8):846-850. PubMed ID: 28423962 [TBL] [Abstract][Full Text] [Related]
20. [The role of fecal calprotectin in the diagnosis and treatment of gastrointestinal diseases]. Iliás Á; Rózsa FP; Gönczi L; Lovász BD; Kürti Z; Lakatos PL Orv Hetil; 2019 Mar; 160(9):322-328. PubMed ID: 30798622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]